The future of microfluidic point-of-care diagnostic devices

“To make this [personalized medicine] a reality requires the combination of already developed microfluidic components into point-of-care devices that are minimally invasive, accurate, durable, user-friendly and low cost.” “Point-of-care diagnostic devices founded in microfluidic technologies will lead the change to personalized medicine, thereby, having a great effect in the diagnosis and treatment of diseases.” A recent National Institutes of Health report [1] suggests that point-of-care (POC) testing has the potential to effect a paradigm shift from curative to predictive, personalized and preemptive medicine [2]. POC testing promotes a shift away from traditional diagnostic tests in the clinical laboratory setting to...